GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surgical Innovations Group PLC (LSE:SUN) » Definitions » EBITDA Margin %

Surgical Innovations Group (LSE:SUN) EBITDA Margin % : 1.51% (As of Dec. 2023)


View and export this data going back to 1988. Start your Free Trial

What is Surgical Innovations Group EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Surgical Innovations Group's EBITDA for the six months ended in Dec. 2023 was £0.10 Mil. Surgical Innovations Group's Revenue for the six months ended in Dec. 2023 was £6.36 Mil. Therefore, Surgical Innovations Group's EBITDA margin for the quarter that ended in Dec. 2023 was 1.51%.


Surgical Innovations Group EBITDA Margin % Historical Data

The historical data trend for Surgical Innovations Group's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Surgical Innovations Group EBITDA Margin % Chart

Surgical Innovations Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.05 -13.97 2.71 5.54 1.34

Surgical Innovations Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.16 4.30 6.66 1.15 1.51

Competitive Comparison of Surgical Innovations Group's EBITDA Margin %

For the Medical Devices subindustry, Surgical Innovations Group's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Surgical Innovations Group's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surgical Innovations Group's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Surgical Innovations Group's EBITDA Margin % falls into.



Surgical Innovations Group EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Surgical Innovations Group's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=0.161/12.014
=1.34 %

Surgical Innovations Group's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=0.096/6.364
=1.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Surgical Innovations Group  (LSE:SUN) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Surgical Innovations Group EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Surgical Innovations Group's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Surgical Innovations Group (LSE:SUN) Business Description

Traded in Other Exchanges
N/A
Address
Clayton Wood House, 6 Clayton Wood Bank, Leeds, GBR, LS16 6QZ
Surgical Innovations Group PLC is involved in the design, development, manufacture, and sale of devices for use in minimally invasive surgery and precision engineering markets. The group sells branded products through independent healthcare distributors across the world and own-label products through original equipment manufacturer relationships. The SI Brand segment includes research, development, manufacture, and distribution of SI branded minimally invasive devices. The OEM segment includes the research, development, manufacture, and distribution of minimally invasive devices for third-party medical device companies through either own label or co-branding. The distribution segment includes the distribution of specialist medical products.